April 21, 2010 – The growing number of Americans with cardiovascular disease has caused a heightened sensitivity in the evaluation of chest pain.
April 21, 2010 – Nearly 50 percent of survey respondents said they would adopt optical coherence tomography (OCT) intravascular imaging systems when they become available in the United States. The survey of Diagnostic & Invasive Cardiology readers took place online from March through April.
April 21, 2010 - Performing coronary computed tomography angiography (CTA) saved $789 in patients who had positive stress test results but a less than 50 percent chance of having significant coronary artery disease (CAD) compared to invasive cardiac catheterization, reported a study in the May issue of the American Journal of Roentgenology.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
April 21, 2010 - The U.S. Food and Drug Administration (FDA) launched the Center for Devices and Radiological Health (CDRH) Transparency Website today as part of the agency's transparency initiative. The site will provide information about medical device and radiation-emitting product regulatory processes and decisions, and summaries of data that provide the rationale for agency actions.
April 21, 2010 - With the complexity of payer requirements for hospitals increasing as well as the risks associated with using aging technology platforms, more and more health care providers are turning to health IT-based solutions to better manage their critical revenue cycle processes.
April 19, 2010 – A microvolt T-wave alternans (MTWA) original equipment manufacturer (OEM) module is available to better measure small heartbeat irregularities that indicate a patient’s heightened risk for sudden cardiac arrest. The module allows electrocardiogram (ECG) manufacturers to include the technology in their devices.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
April 19, 2010 – The Transcatheter Cardiovascular Therapeutics (TCT) 2010 scientific sessions set for September will provide significant clinical research updates to technologies and practices in interventional cardiology that will directly affect patient care.
April 19, 2010 – The U.S. Food and Drug Administration (FDA) recently cleared a generic version of metoprolol succinate extended-release tablets. The beta-blocker is used to treat angina, heart failure and high blood pressure.
April 14, 2010 – An antibacterial wrap for implanted pacemakers and defibrillators released this week is designed to provide protection against infections. The AigisRx Flat delivers the antimicrobial agents rifampin and minocycline.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
April 14, 2010 – Two external pacemakers were launched in Europe today that offer an intuitive design for safer usage in emergencies and temporary patient care.
April 14, 2010 – The Mount Sinai Medical Center in New York has become the first facility in the United States to commercially use a new cardiac nuclear imaging system that drastically reduces imaging time and radiation exposure.
April 14, 2010 - When college football’s elite enter Radio City Music Hall April 22 for the 2010 National Football League (NFL) draft, it will be after much public analysis of their stats and accomplishments. Also important to a player’s prospect of being drafted is the outcome of diagnostic tests including X-rays, magnetic resonance imaging (MRI) and cardiac evaluations.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
April 13, 2010 – The U.S. Food and Drug Administration (FDA) recently cleared a combined electrocardiogram (ECG) Holter and ambulatory blood pressure monitoring recorder and software analysis system.
April 13, 2010 – A catheter designed to deliver embolic materials and radiopaque media to selected sites in visceral vascular territories recently gained FDA clearance. The Gandras Visci-G is a 5 French, 75 cm catheter with a primary curve and a flexible 1 cm tip, making it useful for precise and stable placement in renal, mesenteric or abdominal catheterization procedures.
April 13, 2010 – More than 300 patients in Europe have been enrolled in a real-world study to assess the effectiveness of a coronary bifurcation stent. Enrollment was completed last week in E-Tryton 150 and E-Tryton Benelux, two European registry studies evaluating the Tryton Side Branch Stent System for the treatment of atherosclerotic lesions in the side branch at the site of a bifurcation.